164 related articles for article (PubMed ID: 30660652)
1. Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression.
Yan H; Dong M; Liu X; Shen Q; He D; Huang X; Zhang E; Lin X; Chen Q; Guo X; Chen J; Zheng G; Wang G; He J; Yi Q; Cai Z
Cancer Lett; 2019 Apr; 446():38-48. PubMed ID: 30660652
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma.
Yan H; He D; Qu J; Liu Y; Xu R; Gu H; Chen J; Li Y; Zhang E; Zhao Y; He J; Cai Z
Cancer Immunol Immunother; 2023 Feb; 72(2):327-338. PubMed ID: 35881196
[TBL] [Abstract][Full Text] [Related]
4. Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-α pathway.
Burassakarn A; Srisathaporn S; Pientong C; Wongjampa W; Vatanasapt P; Patarapadungkit N; Ekalaksananan T
Oral Oncol; 2021 Jun; 117():105279. PubMed ID: 33819809
[TBL] [Abstract][Full Text] [Related]
5. Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages.
Zhao Q; Kuang DM; Wu Y; Xiao X; Li XF; Li TJ; Zheng L
J Immunol; 2012 Feb; 188(3):1117-24. PubMed ID: 22184722
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.
Bonanno G; Mariotti A; Procoli A; Folgiero V; Natale D; De Rosa L; Majolino I; Novarese L; Rocci A; Gambella M; Ciciarello M; Scambia G; Palumbo A; Locatelli F; De Cristofaro R; Rutella S
J Transl Med; 2012 Dec; 10():247. PubMed ID: 23232072
[TBL] [Abstract][Full Text] [Related]
7. The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: focus on macrophage polarization of THP-1 cells.
Wang XF; Wang HS; Wang H; Zhang F; Wang KF; Guo Q; Zhang G; Cai SH; Du J
Cell Immunol; 2014; 289(1-2):42-8. PubMed ID: 24721110
[TBL] [Abstract][Full Text] [Related]
8. IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
Carbotti G; Barisione G; Airoldi I; Mezzanzanica D; Bagnoli M; Ferrero S; Petretto A; Fabbi M; Ferrini S
Oncotarget; 2015 Dec; 6(41):43267-80. PubMed ID: 26657115
[TBL] [Abstract][Full Text] [Related]
9. Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s).
Guo F; Hu M; Huang D; Zhao Y; Heng B; Guillemin G; Lim CK; Hawthorne WJ; Yi S
Xenotransplantation; 2017 Sep; 24(5):. PubMed ID: 28771838
[TBL] [Abstract][Full Text] [Related]
10. Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner.
Jung JY; Gleave Parson M; Kraft JD; Lyda L; Kobe B; Davis C; Robinson J; Peña MM; Robinson CM
Immunology; 2016 Sep; 149(1):35-47. PubMed ID: 27238498
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently.
Currier AR; Ziegler MH; Riley MM; Babcock TA; Telbis VP; Carlin JM
J Interferon Cytokine Res; 2000 Apr; 20(4):369-76. PubMed ID: 10805371
[TBL] [Abstract][Full Text] [Related]
12. [Expression of indoleamine 2, 3-dioxygenase modulates macrophage polarization in THP-1 cells].
Wang X; Wang H; Zhang F; Liu H; Du J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):901-5. PubMed ID: 25200149
[TBL] [Abstract][Full Text] [Related]
13. Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor.
Ryu YH; Kim JC
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4148-52. PubMed ID: 17724200
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1.
Hissong BD; Byrne GI; Padilla ML; Carlin JM
Cell Immunol; 1995 Feb; 160(2):264-9. PubMed ID: 7720088
[TBL] [Abstract][Full Text] [Related]
15. Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis.
Liu Y; Yan H; Gu H; Zhang E; He J; Cao W; Qu J; Xu R; Cao L; He D; Zhang J; Hou Y; Cai Z
Oncoimmunology; 2022; 11(1):2057837. PubMed ID: 35371618
[TBL] [Abstract][Full Text] [Related]
16. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production.
Larussa T; Leone I; Suraci E; Nazionale I; Procopio T; Conforti F; Abenavoli L; Hribal ML; Imeneo M; Luzza F
Helicobacter; 2015 Feb; 20(1):41-8. PubMed ID: 25308308
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells.
He YW; Wang HS; Zeng J; Fang X; Chen HY; Du J; Yang XY
Life Sci; 2013 Oct; 93(15):509-15. PubMed ID: 23942267
[TBL] [Abstract][Full Text] [Related]
19. Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes.
Carlin JM; Borden EC; Sondel PM; Byrne GI
J Leukoc Biol; 1989 Jan; 45(1):29-34. PubMed ID: 2463322
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
